XML 56 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Valuation Method Used to Calculate Level 3 Liabilities Measured at Estimated Fair Value of Contingent Consideration Related to Acquisition (Detail) - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended
Jul. 31, 2014
Dec. 31, 2017
Mar. 31, 2017
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Contingent consideration   $ 10,423 $ 9,153
ECP Entwicklungsgesellschaft mbH      
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Discount rate 21.00%    
Level 3      
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Contingent consideration   10,423 $ 9,153
Level 3 | ECP Entwicklungsgesellschaft mbH      
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Contingent consideration   10,423  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone      
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Contingent consideration   $ 5,654  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone | Base Case Scenario | Contingent Consideration      
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Probability of occurrence   40.00%  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone | Minimum | Contingent Consideration      
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Projected fiscal year of milestone payments   2019  
Discount rate   2.80%  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone | Minimum | Various Upside and Downside Scenarios | Contingent Consideration      
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Probability of occurrence   12.00%  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone | Maximum | Contingent Consideration      
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Projected fiscal year of milestone payments   2022  
Discount rate   3.30%  
Level 3 | ECP Entwicklungsgesellschaft mbH | Probability weighted income approach | Clinical and regulatory milestone | Maximum | Various Upside and Downside Scenarios | Contingent Consideration      
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Probability of occurrence   30.00%  
Level 3 | ECP Entwicklungsgesellschaft mbH | Monte Carlo simulation model | Revenue-based milestone      
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Contingent consideration   $ 4,769  
Level 3 | ECP Entwicklungsgesellschaft mbH | Monte Carlo simulation model | Revenue-based milestone | Contingent Consideration      
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Discount rate   18.00%  
Expected volatility for forecasted revenues   50.00%  
Level 3 | ECP Entwicklungsgesellschaft mbH | Monte Carlo simulation model | Revenue-based milestone | Minimum | Contingent Consideration      
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Projected fiscal year of milestone payments   2023  
Level 3 | ECP Entwicklungsgesellschaft mbH | Monte Carlo simulation model | Revenue-based milestone | Maximum | Contingent Consideration      
Fair Value Inputs, Liabilities, Quantitative Information [Line Items]      
Projected fiscal year of milestone payments   2035